Probablistic histograms. Probabilistic distribution (1st to 100th percentile) of iNMB for rapid testing compared with (1) in-house and (2) send-out testing for each of 4 base-case scenarios: (i) PLASMIC = 5, TPE with caplacizumab (A and B); (ii) PLASMIC = 5, TPE without caplacizumab (C and D); (iii) PLASMIC = 6-7, TPE with caplacizumab (E and F); and (iv) PLASMIC = 6-7, TPE without caplacizumab (G and H). The x- and y-axes are aligned to be identical across all 8 distributions. Positive iNMB (ie, >$0, moving right on the x-axis) favors the rapid strategy.